Henry Schein Inc. (HSIC)

Schlusskurs vom Vortag:

$68.60

Offen:

$68.71

24-Stunden-Volumen:

584.86K

Marktkapitalisierung:

$8.79B

Einnahmen:

$12.34B

Nettoeinkommen (Verlust:

$416.00M

KGV:

19.93

EPS:

3.42

Netto-Cashflow:

$313.00M

1W Leistung:

-6.80%

1M Leistung:

-7.19%

6M Leistung:

+9.23%

1J Leistung:

-14.81%

1-Tages-Spanne:

$68.17

$69.31

52-Wochen-Spanne:

$60.01

$82.63

Henry Schein Inc. Stock (HSIC) Company Profile

Firmenname

Henry Schein Inc.

Sektor

Healthcare (1223)

Branche

Medical Distribution (11)

Telefon

631-843-5500

Adresse

135 Duryea Road, Melville, NY

Mitarbeiter

22,000

Twitter

@henryschein

Nächster Verdiensttermin

2024-05-14

Neueste SEC-Einreichungen

HSIC's Discussions on Twitter

Henry Schein Inc. Stock (HSIC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-12	Hochstufung	JP Morgan	Neutral → Overweight
2023-11-10	Hochstufung	Stifel	Hold → Buy
2022-08-08	Hochstufung	UBS	Sell → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Neutral
2022-06-14	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-05-13	Fortgesetzt	Credit Suisse	Outperform
2022-01-31	Eingeleitet	Morgan Stanley	Underweight
2022-01-07	Hochstufung	Credit Suisse	Neutral → Outperform
2021-10-01	Fortgesetzt	Credit Suisse	Neutral
2021-02-08	Fortgesetzt	Piper Sandler	Overweight
2021-01-04	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-11-03	Hochstufung	Barrington Research	Mkt Perform → Outperform
2020-05-06	Herabstufung	Barrington Research	Outperform → Mkt Perform
2020-04-07	Hochstufung	Goldman	Neutral → Buy
2020-04-02	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-01-09	Herabstufung	BofA/Merrill	Neutral → Underperform
2020-01-02	Hochstufung	Evercore ISI	Underperform → In-line
2019-08-07	Herabstufung	William Blair	Outperform → Mkt Perform
2019-05-30	Eingeleitet	Wolfe Research	Underperform
2019-05-15	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-04-18	Eingeleitet	Guggenheim	Buy
2019-01-17	Eingeleitet	UBS	Sell
2019-01-03	Herabstufung	Evercore ISI	In-line → Underperform
2019-01-02	Herabstufung	Robert W. Baird	Outperform → Neutral
2018-11-08	Bestätigt	Barrington Research	Outperform
2018-10-25	Herabstufung	Edward Jones	Hold → Sell
2018-10-19	Fortgesetzt	Goldman	Neutral
2018-10-04	Bestätigt	Robert W. Baird	Outperform
2018-08-07	Bestätigt	Stifel	Hold
2018-04-24	Herabstufung	Goldman	Buy → Neutral
2018-04-04	Hochstufung	Leerink Partners	Mkt Perform → Outperform

Alle ansehen

Henry Schein Inc. Aktie (HSIC) Neueste Nachrichten

West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates

Zacks Investment Research

Align Technology (ALGN) Surpasses Q1 Earnings and Revenue Estimates

Zacks Investment Research

Henry Schein (HSIC) Gears Up for Q1 Earnings: Factors to Note

Zacks Investment Research

Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis

Benzinga

Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay

Zacks Investment Research

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Zacks Investment Research

Finanzdaten der Henry Schein Inc.-Aktie (HSIC)

Henry Schein Inc. (HSIC) Umsatz 2024

Henry Schein Inc. (HSIC) Nettogewinn 2024

Henry Schein Inc. (HSIC) Free Cashflow 2024

Henry Schein Inc. (HSIC) Gewinn je Aktie 2024

Henry Schein Inc.-Aktie (HSIC) Insiderhandel